Barely Significant
← all excerpts

Targeting Temozolomide-Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor.

Cancer Med · 2026 · PMC13314717 · PMID 42374654

1
hedged sentence
closest p
boldest claim

The sentences

It confirmed that the combination was more effective than either TMZ or BA‐101 alone, although the comparisons did not reach statistical significance (Figure 6 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.